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Pre-Workflow Modifications  
(Biochemical & Enzymatic 
Identification) 
Post-Workflow Modifications 
(MALDI-TOF Only) 
Post-Workflow Modifications 
(MALDI-TOF + Biofire) 
  
Organism 
Average TAT, 
hours (N) 
Standard 
deviation  (±) 
Average TAT, 
hours (N) 
Standard 
deviation (±) 
Average TAT, 
hours (N) 
Standard 
deviation (±) 
p-value 
(<0.05) 
Methicillin susceptible Staphylococcus aureus (MSSA) 44.7 (56) 17.8 30.2(47) 14.6 34.5 (47) 23.7 0.177 
Methicillin resistant Staphylococcus aureus (MRSA) 43.3 (18) 10.2 64.0(15) 21.5 21.3 (25) 13.1 2.519x10-07 
Escherichia coli 62.1 (62) 10.4 27.1(69) 12.2 22.7 (73) 13.3 2.616x10-40 
Pseudomonas aeruginosa 69.7 (18) 18.3 42.1(12) 20.1 34.1 (10) 11.8 1.599x10-06 
Streptococcus pneumoniae 35 (5) 9.30 20.1(2) 0.02 11.7 (8) 4.6 0.003 
Beta-hemolytic Streptococcus (GRP A) 37.2 (1) - 26.1(3) 14.3 13.5 (4) 5.2 - 
Beta-hemolytic Streptococcus (GRP B) 43.7 (6) 16.2 28.5(7) 19.5 38.2 (6) 20.6 0.619 
Candida glabrata 84.3 (6) 30.9 74.5 (7) 14.6 69.3 (6) 19.8 0.344 
Candida albicans/dubliniensis 76.4 (6) 18.4 76.2 (6) 18.31 76.4 (7) 27.3 0.0002 
Enterobacter cloacae complex/ E. aerogenes 63.1 (5) 12.7 34.0(17) 31.8 19.95 (8) 9.46 0.0004 
Proteus mirabilis 82.4 (7) 29.5 35.5(5) 18.2 43.2 (4) 22.4 0.038 
Klebsiella pneumoniae 62.5 (29) 11.0 25.3(29) 12.9 27.98(27) 21.4 5.029x10-09 
Klebsiella pneumonia + KPC NA NA NA NA 14.8 (5) 2.3 - 
Enterococcus species NA NA NA NA 20.3 (6) 6.7 - 
Enterococcus faecalis/faecium VRE 68.3 (6) 13.3 60.2 (4) 19.2 22.7 (8) 8.3 7.033x10-05 
Enterococcus faecalis/faecium 70.3 (27) 17.2 35.0 (14) 10.3 38.1 (18) 25.6 0.0005 
Universal Staphylococcus species NA NA NA NA 33.97 (74) 21.1 6.140x10-31 
Coagulase negative Staphylococcus, including Staph. 
lugdunensis 
78.1 (159) 19.1 50.9(185) 19.7 54.4 (86) 20.73 2.297x10-15 
Abstract 
Background: 
Emergence of direct from positive blood culture bottle identification (ID) methods 
reveal opportunities for improving bacterial ID and select resistance marker 
detection turn-around-times.  Each system has various advantages and 
disadvantages; each institution must select the method/s that best fit the laboratory 
and patient needs. Here we elucidate improvements in 24 hour workflow through 
incorporating multiple rapid technologies for positive blood culture ID into a 24 
hour algorithm.  
 
Methods: 
MALDI-TOF (Bruker) analysis with sepsityper extraction (aerobic Gram-positive 
and anaerobic bacteria); MALDI-TOF analysis with serum separator tube 
concentration (Gram-negative bacteria); and a FilmArray Blood Culture Panel 
(Biofire) were utilized.  MALDI was utilized on 1st shift for single bacterium 
positives. FilmArray was performed on 2nd and 3rd shift for aerobic bottles and on 
1st shift for gram-positive cocci in clusters and Candida.  We examined all events 
during our pre-modification (September-November 2013) and post-modification 
(late-December 2014-March 2015) time periods and defined an event as the first 
positive blood culture for a patient within the examined data period.  The 
Antimicrobial Stewardship Pharmacist (ASP) was notified with identifications and 
also KPC carbapenemase positives, to implement a carbapenem-resistant 
Enterobacteriaceae (CRE) empiric treatment algorithm.  For KPC positives (CRE) a 
custom minimum inhibitory concentration (MIC) panel was utilized, replacing a 
standard susceptibility panel and Etests. Finally, 2nd shift began susceptibility setup 
on subcultured bloods that had turned positive from 11 p.m.-6 a.m. 
 
Results: 
Pre- and post- workflow modification average turn-around times (TAT) and p-values 
are shown in the Table. Detection of either the KPC or the mecA marker 
significantly improved the TAT needed for phenotypic detection of carbapenem or 
methicillin resistance. KPC was detected in 3 Enterobactericeae.  
 
Conclusions: 
Improvements to patient care are to be determined, but strong collaboration with 
ASP is anticipated to make a significant impact on patient outcomes. Of note, while 
having a universal Staphylococcus species target is useful, it can lead to 
complications with multi-species positive bottles. With the universal Staphylococcus 
species target, it is not possible to differentiate between a mixed coagulase negative 
Staphylococcus species (CNSS) versus Staphylococcus aureus when both are 
present as the CNSS may harbor the mecA target, preventing adequate treatment. 
Furthermore, a Staphylococcus lugdunensis specific marker would be clinically 
useful. 
Table 1: Turn-around-time Improvements Noted Over Time 
Future Considerations 
• Determine if patient outcomes were impacted by improvement in time-to-identification of organisms  
• Evaluation of Antimicrobial Stewardship Pharmacist recommendations and patient Care-Team actions 
• Types of intervention performed 
• Assess time to appropriate antimicrobial therapy  and Length of Stay (LOS) impact 
• Determine if unnecessary antibiotic exposure was minimized through differentiation of coagulase negative 
Staphylococcus (potential contaminants) from Staphylococcus aureus as well as through educational initiatives 
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Time-line of Workflow 
Data Communication 
• Email of all positive blood culture identifications generated and sent to 
Antimicrobial Stewardship Pharmacists at least twice daily 
• Clinician (Care-team) directly notified with identification at time 
determined 
• Direct 24/7 phone call for KPC positive Enterobacteriaceae to a 
Antimicrobial Stewardship Pharmacist 
MALDI-TOF plus Biofire Blood Culture Algorithm 
